A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Free
Discussion Forum: Valeo Pharma Inc.
List Message View
Thread Message View
New Message
Message Title
Rating
Author / Date
Icon agoracom AGORACOM Small Cap 60: Clinical study of Valeo Immune Booster Yields Encouraging Results, May Help Reduce COVID-19 Associated Symptoms

AGORACOM
Jan 18, 2022 10:58AM
Icon agoracom AGORACOM Small Cap 60: Valeo Pharma Immune booster now available in 300 stores under Loblaws banners

AGORACOM-KE
Jan 14, 2022 04:16PM
Icon agoracom AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) Commercializes Drugs from other Parts of the World

AGORACOM-KE
Jan 12, 2022 04:31PM
Icon agoracom Valeo Pharma's Hesperco™ Now Available At Loblaws, Hesperidin Covid-19 Clinical Trial Results Submitted For Publication

AGORACOM-KE
Jan 05, 2022 07:00AM
Icon agoracom VIDEO – Valeo Pharma Obtains Public Reimbursement For Asthma Drugs In Quebec and Nova Scotia, Another Step Closer to 2025 Revenue Target of $160M

AGORACOM
Dec 17, 2021 04:28PM
Icon agoracom INTERVIEW ALERT: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB)

AGORACOM-KE
Dec 17, 2021 01:49PM
Icon agoracom Valeo Pharma Obtains Public Reimbursement For Enerzair® Breezhaler® And Atectura® Breezhaler® In Quebec And Nova Scotia

AGORACOM-KE
Dec 15, 2021 07:00AM
Icon agoracom Valeo Pharma Closes Previously Announced Upsized $15 Million Bought Deal Private Placement And Concurrent $10 Million Private Placement...

AGORACOM-KE
Dec 09, 2021 02:51PM
Icon agoracom AGORACOM Small Cap 60: Valeo Pharma Says Physician Response Has Been Very Favourable To Company’s Asthma Drugs

AGORACOM
Nov 25, 2021 01:42PM
Icon agoracom Valeo Pharma Announces Upsize of Previously Announced Bought Deal Private Placement of Convertible Debentures to $15 Million With Concurrent $10 M...

AGORACOM
Nov 24, 2021 04:46PM
Icon agoracom AGORACOM Small Cap 60: Valeo Pharma Extremely Pleased With Both Public and Private Reimbursement Status of Asthma and Blood Thinner Drugs

AGORACOM
Nov 19, 2021 01:47PM
Icon agoracom AGORACOM Small Cap 60: Does Public Reimbursement for Valeo’s Asthma Drugs In Alberta Open The Door to Other Provinces?

AGORACOM
Nov 18, 2021 01:45PM
Icon agoracom AGORACOM Small Cap 60: What Gives Valeo Pharma The Competitive Advantage on its Asthma Drugs

AGORACOM
Nov 17, 2021 11:28AM
Icon agoracom AGORACOM Small Cap 60: How Critical Is It For A Drug To Secure Provincial Reimbursement?

AGORACOM
Nov 15, 2021 12:34PM
Icon agoracom Valeo Pharma Obtains Public Reimbursement for Redesca™ and Redesca Hp™ in Quebec

AGORACOM-KE
Nov 15, 2021 08:21AM
Icon agoracom AGORACOM Small Cap 60: Valeo Pharma Obtains Public Reimbursement For Its Asthma Drugs In Alberta

AGORACOM
Nov 12, 2021 03:54PM
Icon agoracom AGORACOM Small Cap 60: Valeo Pharma Is A Commercial Stage Revenue Generating and Profitable Pharma Company

AGORACOM
Nov 11, 2021 03:31PM
Icon agoracom INTERVIEW ALERT: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB)

AGORACOM
Nov 04, 2021 12:00PM
Icon agoracom AGORACOM Small Cap 60: Valeo Pharma Has Built-Out Team Consisting of ~100 Employees

AGORACOM
Nov 03, 2021 11:48AM
Icon agoracom Valeo Pharma Obtains Public Reimbursement For Enerzair® Breezhaler® and Atectura® Breezhaler® In Alberta

AGORACOM
Nov 03, 2021 07:00AM
New Message